Western Blot of cancer cell lines LnNCap (lane 1) and BT-474 (lane 2) showing specific immunolabeling of KLK-L3.
Anti-KLK-L3 (KLK9) Antibody
Bulk Order Anti-KLK-L3 (KLK9) Antibody
Kallikreins are a subgroup of serine proteases and are implicated in carcinogenesis. (KLK-L3; HGMW-approved symbol KLK9) is a novel kallikrein gene with utility for diagnosis, monitoring and therapeutics of various cancers including those of the breast, prostate and testis.
Antigen Affinity Purified
Synthetic peptide corresponding to amino acids from the C-terminal region of human KLK9 protein
Recommended that the undiluted antibody be aliquoted into smaller working volumes (10-30 uL/vial depending on usage) upon arrival and stored long term at -20° C or -80° C, while keeping a working aliquot stored at 4° C for short term. Avoid freeze/thaw cycles. Stable for at least 1 year.
PBS + 0.02% NaN3
WB Brain: 1:500-1:1000
Reacts with the C-terminal region of the human KLK-L3 (KLK9) protein.
Western blots performed on each lot.
For research use only. Not intended for therapeutic or diagnostic use. Use of all products is subject to our terms and conditions, which can be viewed on our website.
After date of receipt, stable for at least 1 year at -20°C.